相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
Vince B. C. Biemans et al.
JOURNAL OF CROHNS & COLITIS (2020)
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates
Bram Verstockt et al.
JOURNAL OF CROHNS & COLITIS (2019)
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study
Claire Liefferinckx et al.
JOURNAL OF CROHNS & COLITIS (2019)
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry
M. Iborra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
Anja Eberl et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease
Fabio Salvatore Macaluso et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naive and Non-naive Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease
Fabio Salvatore Macaluso et al.
JOURNAL OF CROHNS & COLITIS (2019)
Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria
Sadik Saman et al.
INTESTINAL RESEARCH (2019)
Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study
C. R. Rowan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases
Fabio Salvatore Macaluso et al.
DIGESTIVE AND LIVER DISEASE (2018)
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease
Paul Rutgeerts et al.
GASTROENTEROLOGY (2018)
Next generation of small molecules in inflammatory bowel disease
Pablo Olivera et al.
GUT (2017)
Ustekinumab use in Crohn's disease: a Canadian tertiary care centre experience
Astrid-Jane Greenup et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease
Robert Battat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort
C. Ma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Ustekinumab for the Treatment of Refractory Crohn's Disease: The Spanish Experience in a Large Multicentre Open-label Cohort
Sam Khorrami et al.
INFLAMMATORY BOWEL DISEASES (2016)
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
A. Menter et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-The McGill experience
U. Kopylov et al.
JOURNAL OF CROHNS & COLITIS (2014)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
